GlassScriptPhysician profile
Maria V Indihar
NPI 1184809873
$8,491.61
in general payments reported to CMS, 2019-2025
14 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,576 · 2022: $240 · 2023: $5,319 · 2024: $83.12 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,180 · Food and Beverage: $342 · Travel and Lodging: $140 · Education: $12.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,180.00 |
| Food and Beverage | $342.34 |
| Travel and Lodging | $140.00 |
| Education | $12.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $5,564.59 | 2022-2025 | |
| Mylan Specialty L.P. | $2,500.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.00 | 2025 | |
| Chiesi USA, INC. | $89.17 | 2021-2023 | Bronchitol |
| Baxter Healthcare | $35.84 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $35.60 | 2025 | Brinsupri, Arikayce |
| Aimmune Therapeutics, INC. | $22.05 | 2025 | Zenpep |
| Axsome Therapeutics, INC. | $19.52 | 2025 | Sunosi |
| Glaxosmithkline, LLC. | $19.10 | 2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Azurity Pharmaceuticals, INC. | $15.57 | 2024 | Horizant |
| United Therapeutics Corporation | $15.17 | 2023 | Remodulin |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Indihar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.